Status:
UNKNOWN
Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions:
Dengue Fever
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Dengue is an arthropod-borne disease, found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas. Unfortunately, there is no intervention available to stop dengue seve...
Detailed Description
Rationale of the Study: Bangladesh is a hyperendemic region for dengue infection and is inflicted with massive outbreaks throughout nations since 2019. According to DGHS report, the highest admissions...
Eligibility Criteria
Inclusion
- Age \>18 to 65 years.
- NS1 positive people.
- Fever ≥ 100.4°F (≥38°C) for 3days or less
- Typical sign symptoms of Dengue fever.
Exclusion
- \>72hours of fever.
- Critically ill patients.
- Pregnancy
- Known Vitamin D hypersensitivity
- High serum calcium level
- Hypoalbuminaemia
- Malignancy
- Known nephrolithiasis and severe renal impairment.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06071481
Start Date
June 1 2023
End Date
February 15 2024
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bangabandhu Sheikh Mujib Medical University
Dhaka, Bangladesh, 1200